chrisvoncsefalvay/vaers-outcomes huggingface dataset:
1/6/21: 1245 am. Chills. Fever, headache, body aches, fatigue  1/6/21: 1:30pm tmep 99.7, body aches. Fatigue. Chills
Patient was given the bivalent booster dose first and had not received his primary series//no known adverse effects
Caller states she may have had diarrhea while receiving the vaccine, but has since been diagnosed with C-diff./colitis difficile; C-difficile; This is a spontaneous report form a contactable consumer. A unspecified age elderly female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for Injection, Batch/Lot number: Unknown), via unspecified route of administration on an unknown date in Mar2021 (reported as Early march) as 1st dose, single for COVID-19 immunization. The patient received 2nd dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for Injection, Batch/Lot number: Unknown), via unspecified route of administration on an unknown date (6 weeks after first dose), as 2nd dose, single for COVID-19 immunization. Medical history and concomitant medications were not reported. On an unknown date, the patient complained of Clostridium difficile after receiving the Pfizer Covid vaccine. Caller stated that she may have had diarrhea while receiving the vaccine. On an unknown date, she had been diagnosed with clostridium difficile. She was treated with multiple unspecified antibiotics for months and was currently being treated with Vancomycin 2 times daily. The patient stated that she approached multiple physician visits, including gastroenterology in an effort to determine if Celiac disease, or irritable bowel syndrome are the cause of the C-diff. Caller was very upset that she took the Pfizer covid vaccine, although she reported that she was aware of someone else going through the same experience after taking the Moderna Vaccine. The patient wanted to know if heard of side effect colitis difficile (C-diff) from vaccine because she had the C-diff now but not before the first dose. The patient wanted to know if this could be a side effect. She was asking because her friends sister had the same experience not from the Pfizer Covid vaccine but from Moderna. Consumer stated, she was trying to find out if some condition that she had developed after getting the Covid vaccine could be possible or it was just a co-incidence. The outcome of the event was unknown.  Information on batch/Lot number has been requested.
received the second COVID vaccine on 16Mar2021 and was diagnosed with COVID (positive COVID test, had symptoms) on 19Apr2021; received the second COVID vaccine on 16Mar2021 and was diagnosed with COVID (positive COVID test, had symptoms) on 19Apr2021; This is a spontaneous report from a contactable consumer. An adult female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) second dose via an unspecified route of administration on 16Mar2021 (Batch/Lot Number: Unknown) as single dose for covid-19 immunisation. The patient was not pregnant at the time of vaccination. The patient's medical history and concomitant medications were not reported. The patient received the second COVID vaccine on 16Mar2021 and was diagnosed with COVID (positive COVID test, had symptoms) on 19Apr2021. Outcome of the event was unknown.  Information on the lot/batch number has been requested.
This spontaneous report as received from a company representative refers to her 43 year old husband with LEVAQUIN allergy to leukopenia. On 10-MAY-2013 the patient was vaccinated subcutaneously with one shot of M-M-R II (lot # H013042, expiry date reported as 31-JUL-2014, dose and site unspecified). There was no concomitant medication. On 12-MAY-2013, 3 days after vaccination the patient experienced fever, chills and body aches. The patient had not sought medical attention. No treatment was given. No laboratory diagnostics studies were performed. The outcome of chills, fever and body aches was reported as not recovered/not resolved. Additional information has been requested.
This is a spontaneous report from a contractable physician via a Pfizer sales representative. A 16-year-old male patient of an unspecified ethnicity received first dose of TRUMENBA, via an unspecified route of administration on an unspecified date, single dose. The patient medical history and the patient's concomitant medications were not reported. The patient experienced weakness on an unspecified date with outcome of unknown. Follow-up (10JUL2016): Follow-up attempts are completed. No further information is expected.
Pt recvd Engerix-B on 9JAN91 & 9JUN91 & w/in a day of both vax pt devel joint pain, a rash on face & swelling of lymph nodes; Pt was examined by a dermatologist & Metrogel cream used to treat rash;
Limp episode lasting about 12 h. Infant nursed fairly well but mother reports poor head control, inability to sit or bear weight on legs.
Information has been received from a physician concerning a female who was vaccinated with her first dose with Gardasil. Subsequently the patient experienced joint pain and ache. Additional information has been requested.  This is in follow-up to report (s) preveiously submittedon 4/13/2007. Initial and follow-up information has been received from a physician concerning a female who was vaccinated with her first dose of GARDASIL vaccine. Subsequently the patient experienced joint pain and ache. It was undecided whether the patient would receive the second vaccination. No further information is available.
Rash with sores on her genitalia started 2 days after starting oral typhoid. Said the vaccine made her feel "awful" when she took it. She put on coconut oil and used some other essential oils and "natural" products. She still completed the series and went on her trip. She was very uncomfortable after getting back and called me. I talked with my doctor and we discussed need for STD testing. Sent her to her OB. Was very insistent that "she hadn't been with anyone but her husband and that he hadn't been with anyone but her" OB told her it looked like herpes and tested her for it. Gave her a course of acyclovir. She started the Acyclovir and said lesions/rash got better after 3-4 days. MD called and told her herpes test was negative. She called me back to report she though it was the vaccine.
Pt complained of felling hot, and stomach upset. He felt nauseous, and requested an ambulance
Sore arm at injection site a few hours after injection Chills, headache, joint soreness, fatigue, lack of appetite, dizziness started on 10/28. Treated with total of ibuprofen 1200mg, naproxen 880mg, 500mg aspirin, 500mg acetaminophen over the course of the 28th and 29th. No noticeable changes, but some sweating started in the evening on the 29th.
Severe Headache, Arm and Shoulder Pain (very bad), Nausea, Tiredness.
Patient came in to store to let us know she has been having arm/neck pain on her left side since she got her Pfizer vaccine on 10/28/22. She also stated she developed lumps on her legs and she had an appointment scheduled with her primary care physician.
headache, nausea, vomiting 15 minutes after vaccine. Trouble speaking/remembering -- EMS transfer
Booster dose given at 0.5ml; This spontaneous case was reported by a consumer and describes the occurrence of ACCIDENTAL OVERDOSE (Booster dose given at 0.5ml) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 27-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-Oct-2021, the patient experienced ACCIDENTAL OVERDOSE (Booster dose given at 0.5ml). On 27-Oct-2021, ACCIDENTAL OVERDOSE (Booster dose given at 0.5ml) had resolved.            Concomitant medication information not provided. Treatment information not provided.
Due to persistent HPV infection I did offer patient Gardasil vaccine as latest CDC recommendations include vaccinating adults up to age 45. Patient accepted this. She asked to be be injected while laying supine on exam table due to "having trouble with needles" and this was done. She was told to rest until she felt well enough to check out. Shortly afterwards a thud was heard and patient was found facedown on the ground, unconscious. She was quickly roused by staff. BP and O2 sat were normal. Patient could not remember what happened. States she was laying on one side, and tried to turn to her other side, then the next thing she remembered was being on the ground surrounded by staff. It is unclear if she lost consciousness before or after she fell to the ground. She was eventually moved to a seated position in the chair. Her husband came to the office. I advised ED evaluation due to the possible head trauma. She did state that her face and top of her head hurt. Due to local ED being full, she was advised to go to another facility. Her husband agreed to drive her there.
Two days after injection, I started experiencing preherpetic neuralgia of the left side of my body.  I was experiencing intense pain,  my skin was sensitive to touch. As a precaution to ward off a shingles outbreak I took 1500mg of Valacyclovir.  Afterwards,  blisters started to appear.
Starting on 1/12/21 about 24 hours after vaccination, I felt very severe flu-like symptoms.  I had nausea, chills, felt very lethargic and sore to the point where I couldn't stand at work, and had a pounding headache.  The site where I got the vaccine was also more tender and sore than usual after a vaccination.  I left work early around 3 pm, took 400 mg of ibuprofen every 6 hours and tried to get as much sleep as I could.  By 6 am on 1/13/21, all these symptoms had gone away, but now I've noticed a very swollen lymph node just above my left clavicle.
Pt received flu vaccination at approx. 0930.  Between 1130-1230 pt reports "passing out" in front of computer.  No witnesses around.  Reports a headache pain of 8/10, pressure at top and sides of head.  Pt also reports fatigue and upper body aches.  Pt took 650mg Tylenol at 1440.  Pt recently returned from R&R about 1.5 weeks ago, still not on regular sleep cycle, reports working out, decreased appetite, and decreased water intake.  Reports no caffeine intake except for an energy drink prior to working out, and taking supplements/vitamins.
Felt achy, took alieve and went to work. Got progressively worse, extreme fatigue, nausea and aches by 2:30pm. Injection site hot, puffy and painful. Got home, took another Aleve and slept. Felt better next day, but still achy, nauseous and injection site still hot and sore. Took alieve all day but still felt weak and now slightly flu like soreness around eyes and body weakness, nauseous and nasal congestion. Injection site still hot and sore.
Weakness/tingling.  Respiratory failure requiring intubation.  Suspected acute inflammatory demyelinating polyneuropathy / Guillain-Barre Syndrome.  Received Moderna Covid vaccine on 2/8/21 and 3/8/21 (temporary E-report number 537685).  Received PCV13 vaccine on 4/8/21.
mom reported 6 inch swelling to arm site of DTP; advised ice; APAP given;
Feet tingles/tingles a lot and sometimes the tingles even shock him, It was also stated that tingles sometimes are worse; Makes it hard for him to walk; Throws the patient off balance; Feet fall asleep; Patient received 2nd dose on 36th day after 1st dose/Patient received 2nd dose >35 days since receiving 1st dose; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (Feet tingles/tingles a lot and sometimes the tingles even shock him, It was also stated that tingles sometimes are worse), GAIT DISTURBANCE (Makes it hard for him to walk), BALANCE DISORDER (Throws the patient off balance), HYPOAESTHESIA (Feet fall asleep) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient received 2nd dose on 36th day after 1st dose/Patient received 2nd dose >35 days since receiving 1st dose) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037B21A and 044A21A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (Allergy to Haldol), Drug allergy (Allergy to Seroquel) and Mental disorder since 1997.   On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 22-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient received 2nd dose on 36th day after 1st dose/Patient received 2nd dose >35 days since receiving 1st dose). On an unknown date, the patient experienced PARAESTHESIA (Feet tingles/tingles a lot and sometimes the tingles even shock him, It was also stated that tingles sometimes are worse), GAIT DISTURBANCE (Makes it hard for him to walk), BALANCE DISORDER (Throws the patient off balance) and HYPOAESTHESIA (Feet fall asleep). At the time of the report, PARAESTHESIA (Feet tingles/tingles a lot and sometimes the tingles even shock him, It was also stated that tingles sometimes are worse), GAIT DISTURBANCE (Makes it hard for him to walk), BALANCE DISORDER (Throws the patient off balance), HYPOAESTHESIA (Feet fall asleep) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient received 2nd dose on 36th day after 1st dose/Patient received 2nd dose >35 days since receiving 1st dose) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The concomitant medication included multiple medications but did not mention them. Patient stated on the call that patient  had 3 different tests the doctors ran and cannot figure out what was going on. The patient had symptoms since patient got the covid vaccine shot. No treatment medications were reported.
SICK TO HIS STOMACH, FELT LIGHT HEADED, HOT AND SWEATY AND THEN FREEZING ALL AT THE SAME TIME.
Patient states that left arm began swelling and becoming sore the night of the vaccination. She states that it is warm, tender and swollen. She went to PCP and they gave her a tordal injection to relieve the pain. Instructed to take benadryl and pepcid by PCP.
DTaP - injection site red, swollen and warm to touch (large - 5 x 5 cm). HIB, Prevnar - small red bump (1 x 2 cm). Reactions developed within 12 hours - redness, induration and tenderness.
Tiredness; Nausea; Headache; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Tiredness), NAUSEA (Nausea) and HEADACHE (Headache) in an elderly female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) solution for injection for Crohn's disease.    Concomitant products included LOSARTAN POTASSIUM, ATORVASTATIN and HYDROCHLOROTHIAZIDE for Blood pressure high.   On 28-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) Citrate Free. On an unknown date, the patient experienced FATIGUE (Tiredness), NAUSEA (Nausea) and HEADACHE (Headache). At the time of the report, FATIGUE (Tiredness), NAUSEA (Nausea) and HEADACHE (Headache) had not resolved.            No treatment medications were reported. This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.
Patient came in for her booster shot as she is immunocompromised. Patient completed her two dose series of the Pfizer Vaccine on dates 02/22/2021 and 03/15/2021.   Patient was incorrectly administered the Moderna COVID-19 Vaccine as her 3rd shot. Patient did not report of any adverse side effects and was monitored for 16 minutes after injection.
hard to move my head in any direction; feel like I'm gonna pass out; This spontaneous case was reported by a consumer and describes the occurrence of HEAD DISCOMFORT (hard to move my head in any direction) and FEELING ABNORMAL (feel like I'm gonna pass out) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEAD DISCOMFORT (hard to move my head in any direction) and FEELING ABNORMAL (feel like I'm gonna pass out). At the time of the report, HEAD DISCOMFORT (hard to move my head in any direction) and FEELING ABNORMAL (feel like I'm gonna pass out) outcome was unknown.            No concomitant medications were reported.  No treatment medications were reported.   Reporter did not allow further contact
Patient developed painless left vision loss on April 10, 2021, one day after his second mRNA COVID 19 vaccine.  Episode is secondary to non arteritic ischemic optic neuropathy
mom called pt has welts on legs, face, trunk today;pt recv vax 27AUG97;mom called back & states thought the welts were more from sensitive skin & playing on the grass;
Large, painful welt developed at injection site after both doses. Developed one week after injection with the first dose, within 12 hours with the second.  Developed a severe UTI/Kidney infection within a few days of second dose. Sought treatment on 2/24. These types of infections are rare for me.
SEVERE COPD; Breathing more than usual.; Coughing more than usual.; This spontaneous case was reported by a patient family member or friend and describes the occurrence of CHRONIC OBSTRUCTIVE PULMONARY DISEASE (SEVERE COPD), DYSPNOEA (Breathing more than usual.) and COUGH (Coughing more than usual.) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form and first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced CHRONIC OBSTRUCTIVE PULMONARY DISEASE (SEVERE COPD), DYSPNOEA (Breathing more than usual.) and COUGH (Coughing more than usual.). At the time of the report, CHRONIC OBSTRUCTIVE PULMONARY DISEASE (SEVERE COPD), DYSPNOEA (Breathing more than usual.) and COUGH (Coughing more than usual.) outcome was unknown. Not Provided          No concomitant medication information was provided. No treatment information was provided.
FEELING LOW ENERGY; This spontaneous report received from a patient concerned a male of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808980 and expiry: 21-JUN-2021) dose was not reported, administered on 07-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 08-APR-2021, the subject experienced feeling low energy. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from feeling low energy. This report was non-serious.
she got cold; has fewer; running nose; This case was reported by a consumer via interactive digital media and described the occurrence of cold in a female patient who received Men B NVS (Bexsero) for prophylaxis.   Co-suspect products included meningococcal B recom vaccine + aloh + omv pre-filled syringe device (Bexsero Pre-Filled Syringe Device) injection syringe for prophylaxis.   On an unknown date, the patient received the 1st dose of Bexsero and Bexsero Pre-Filled Syringe Device. On an unknown date, unknown after receiving Bexsero and Bexsero Pre-Filled Syringe Device, the patient experienced cold, fever and runny nose. On an unknown date, the outcome of the cold, fever and runny nose were not recovered/not resolved.   It was unknown if the reporter considered the cold, fever and runny nose to be related to Bexsero and Bexsero Pre-Filled Syringe Device.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were reported as follows: The age at vaccination was not reported. This case was reported by the patient's parent. Vaccination date for 1st dose was discrepantly reported as 4th March 2021. The reporter stated that 2nd dose should be given on 4th March 2021 (at least 2 weeks) but the patient got cold now and the patient had fever and running nose for few days. No further information was reported.
mild injection site pain that felt like a bruise beginning immediately after injection. some swelling around the injection site the following day. chills, mild fever, and headache occurring 10-12 hours after vaccination. the headache improved with over the counter ibuprofen.
Knot in arm bicep; weakness in arm; arm mobility issues, unable to apply weight bearing activities with vaccinated arm; continued pain with movements.
post herpetic neuralgia; cardiovascular event; hearing and balance problems; hearing and balance problems; herpes zoster; Information has been received from a lawyer and a female patient (pt) of unknown age regarding a case in litigation. Information about concurrent condition, medical history and concomitant medication was not reported. On 01-JUN-2015, the pt was vaccinated with zoster vaccine live (ZOSTAVAX) (dose, lot#, expiration date and route were not reported) for routine health maintenance and for its intended purpose: the prevention of shingles (herpes zoster). Shortly after receiving the zoster vaccine live (ZOSTAVAX) vaccine, the pt suffered and continued to suffer from herpes zoster outbreaks, post herpetic neuralgia, a cardiovascular event, as well as hearing and balance problems. As a result of these injuries, Plaintiff was seen and treated by medical providers and was still under their care. As a direct and proximate result of the zoster vaccine live (ZOSTAVAX) vaccine, the pt's symptoms had resulted in physical limitations not present prior to using the product. The pt also experienced mental and emotional distress due to resulting physical limitations and seriousness of her condition. As a result of the zoster vaccine live (ZOSTAVAX), the pt sustained severe and permanent personal injuries. Further, as a tragic consequence of the product, the pt suffered serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. As a direct and proximate result of the product, the pt has suffered and incurred damages, including medical expenses; the loss of accumulations; and other economic and non-economic damages. Outcome of the events was considered as not recovered. The lawyer considered the events to be related to zoster vaccine live (ZOSTAVAX).  The events of herpes zoster outbreaks, post herpetic neuralgia, a cardiovascular event, as well as hearing and balance problems were considered as disabling by the lawyer.
Small red dots started appearing on both lower legs ~15 total on 5/28. Three additional dots have shown up on my right arm, and two on my left arm since then. A few more on my legs since then. Now have ~25 in total. Dots are spread out and are not in any patterns or clusters.